Literature DB >> 21400536

Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis.

Taru Ilmarinen1, Heljä Nissilä, Heikki Rihkanen, Risto P Roine, Petra Pietarinen-Runtti, Anne Pitkäranta, Leena-Maija Aaltonen.   

Abstract

OBJECTIVES/HYPOTHESIS: To determine clinical features, health-related quality of life, and adult voice in patients with a history of juvenile-onset recurrent respiratory papillomatosis (JORRP). STUDY
DESIGN: Case-control study.
METHODS: All 32 patients with JORRP treated at Helsinki University Hospital between 1975 and 1994 were invited to an outpatient visit in spring 2008, and 18 of them (56%) entered the study. Each patient had an age- and gender-matched control subject with similar smoking habits. Videolaryngostroboscopy was performed and voice quality determined by acoustic and perceptual analysis. Voice-quality characteristics of the whole patient group and the recurrence-free patients were examined separately. Subjective voice-related disability was studied with voice handicap index (VHI) and health-related quality of life with a 15D questionnaire.
RESULTS: Acoustic analysis showed that patients had statistically significantly higher values in percent jitter, percent shimmer, and noise-to-harmonics ratio. Perceptual analysis indicated higher scores for patients in overall grade, roughness, breathiness, and strain. Acoustic and perceptual values for recurrence-free patients (n = 14) were also significantly higher than those for their matched paired controls. No statistically significant differences emerged for handicap related to voice or to health-related quality of life. Four study patients (22%) had undergone tracheotomy, indicating severity of juvenile-onset disease.
CONCLUSIONS: JORRP is a risk factor for permanent laryngeal pathology and voice-disturbances in adulthood.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21400536     DOI: 10.1002/lary.21332

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.

Authors:  K Aro; L Bäck; V Loimu; K Saarilahti; S Rogers; H Sintonen; R Roine; Antti Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-28       Impact factor: 2.503

Review 2.  New trends in rehabilitation of children with ENT disorders.

Authors:  R Bovo; P Trevisi; E Zanoletti; D Cazzador; T Volo; E Emanuelli; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

3.  Expression of human papillomavirus and prognosis of juvenile laryngeal papilloma.

Authors:  Juan Li; Tian-Yu Zhang; Le-Tian Tan; Shu-Yi Wang; Yu-Ying Chen; Jie-Yan Tian; Wen-Ying Da; Ping He; Ya-Ming Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Health-related quality of life of head and neck cancer patients with successful oncological treatment.

Authors:  V Loimu; A A Mäkitie; L J Bäck; H Sintonen; P Räsänen; R Roine; K Saarilahti
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-02       Impact factor: 2.503

5.  Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.

Authors:  Mark Jit; Ruth Chapman; Owain Hughes; Yoon Hong Choi
Journal:  BMJ       Date:  2011-09-27

6.  Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States.

Authors:  Elissa Meites; Laura Stone; Raiza Amiling; Vidisha Singh; Elizabeth R Unger; Craig S Derkay; Lauri E Markowitz
Journal:  Clin Infect Dis       Date:  2021-09-07       Impact factor: 20.999

Review 7.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.